As of 2025-07-04, the EV/EBITDA ratio of Selecta Biosciences Inc (SELB) is -1.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SELB's latest enterprise value is 47.20 mil USD. SELB's TTM EBITDA according to its financial statements is -36.19 mil USD. Dividing these 2 quantities gives us the above SELB EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.8x | 10.5x |
| Forward P/E multiples | 11.9x - 20.6x | 16.2x |
| Fair Price | (1.36) - 1.49 | (0.30) |
| Upside | -254.4% - 69.1% | -134.4% |
| Date | EV/EBITDA |